Literature DB >> 2469247

Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries.

C Guettier1, N Hinglais, P Bruneval, M Kazatchkine, J Bariety, J P Camilleri.   

Abstract

The localization of S-protein/Vitronectin as deposits in arterial lesions and as a component of extracellular matrices was investigated by indirect immunofluorescence in ten atherosclerotic samples of carotid endarterectomy compared with ten arteriosclerotic temporal biopsies. Anti-C5b-9 neoantigens, anti-C3, anti-C3d, anti-H, anti-IgG and anti-IgM antibodies were applied on serial sections. In the atherosclerotic plaque, S-protein deposits were observed as irregular granules and spots in the fibrous cap and the internal part of the media at the vicinity of the plaque; they inconstantly colocalized with C5b-9 neoantigens. When present the SC5b-9 complexes were generally associated with cell remnants in the sclerotic matrix. In the temporal artery biopsies, S-protein was bound exclusively to the internal elastic lamina in association with C3d, but was absent from the intimal fibrous thickening. S-protein was not detected as a diffuse component of the extra-cellular matrix of either musculo-elastic or muscular medias, but was clearly demonstrated in smaller arteries; this result suggests a differential distribution of S-protein along the arterial tree.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469247     DOI: 10.1007/bf00734084

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  12 in total

1.  On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies.

Authors:  B R Tomasini; D F Mosher
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

Review 2.  Membrane damage by complement.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Biochim Biophys Acta       Date:  1983-08-11

3.  Immunohistochemical study of the C5b-9 complex of complement in human kidneys.

Authors:  N Hinglais; M D Kazatchkine; S Bhakdi; M D Appay; C Mandet; J Grossetete; J Bariety
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

4.  Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque.

Authors:  H G Rus; F Niculescu; E Constantinescu; A Cristea; R Vlaicu
Journal:  Atherosclerosis       Date:  1986-07       Impact factor: 5.162

5.  Serum spreading factor (vitronectin) is present at the cell surface and in tissues.

Authors:  E G Hayman; M D Pierschbacher; Y Ohgren; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.

Authors:  R J Falk; E Podack; A P Dalmasso; J C Jennette
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

7.  Interaction of vitronectin with collagen.

Authors:  C Gebb; E G Hayman; E Engvall; E Ruoslahti
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

8.  Localization of vitronectin (S-protein of complement) in normal human skin.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

9.  Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions.

Authors:  G K Hansson; J Holm; J G Kral
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-11

10.  Terminal membrane C5b-9 complex of human complement: transition from an amphiphilic to a hydrophilic state through binding of the S protein from serum.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

View more
  12 in total

Review 1.  Evidence for an extra-cellular function for protein kinase A.

Authors:  S Shaltiel; I Schvartz; B Korc-Grodzicki; T Kreizman
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 2.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

3.  Detection of vitronectin mRNA in tissues and cells of the mouse.

Authors:  D Seiffert; M Keeton; Y Eguchi; M Sawdey; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

4.  Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion.

Authors:  J Schneiderman; G M Bordin; I Engelberg; R Adar; D Seiffert; T Thinnes; E F Bernstein; R B Dilley; D J Loskutoff
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1.

Authors:  B Titz; S Dietrich; T Sadowski; C Beck; A Petersen; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

6.  Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.

Authors:  N H Choi-Miura; T Sakamoto; S Ohtaki; H Nakamura; S Ishizawa; Y Takagi; K Gomi; M Tomita
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

7.  Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes.

Authors:  D Seiffert; G M Bordin; D J Loskutoff
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

8.  Prognostic utility of serum vitronectin levels in acute myocardial infarction.

Authors:  S Aslan; B Ikitimur; H A Cakmak; B Karadag; E Y Tufekcioglu; H Ekmekci; H Yuksel
Journal:  Herz       Date:  2014-05-15       Impact factor: 1.443

9.  Increased platelet deposition on atherosclerotic coronary arteries.

Authors:  G H van Zanten; S de Graaf; P J Slootweg; H F Heijnen; T M Connolly; P G de Groot; J J Sixma
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin.

Authors:  Thuzar M Shin; J Mario Isas; Chia-Ling Hsieh; Rakez Kayed; Charles G Glabe; Ralf Langen; Jeannie Chen
Journal:  Mol Neurodegener       Date:  2008-10-21       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.